 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Warning Against Tenofovir+ddI+3TC, and "Triple Nuke" CombinationsOctober 31, 2003 On October 14, 2003 Gilead Sciences warned health care professionals against a using ddI plus 3TC plus tenofovir combination, after many patients on that regimen failed to control the virus and developed mutations to the drugs. The "dear doctor" letter, "High Rate of Virologic Failure in Patients with HIV Infection Treated with a Once-Daily Triple NRTI Regimen containing Didanosine, Lamivudine, and Tenofovir" is on the FDA Website, www.fda.gov/medwatch/SAFETY/2003/viread_deardoc.pdf. The letter also cautioned against all-NRTI regimens in general, as three other such regimens showed disappointing antiviral results in clinical trials.
 This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News. |
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
